data_5099

#Corrected using PDB structure: 1UEAD
#
#N.B. (Observed* = Observed shift + Offset correction)
#
#After reference correction, the following residues still 
#have a HA chemical shift difference (obs*-pred) greater than  0.7ppm:
#NUM  AA    CS     Observed*    Predicted
# 68   S    HA       5.13         4.28
#124   C    HA       4.75         3.98
#
#After reference correction, the following residues still 
#have a CA chemical shift difference (obs*-pred) greater than  5.0ppm:
#NUM  AA    CS     Observed*    Predicted
#124   C    CA      54.02        60.40
#
#After reference correction, the following residues still 
#have a CO chemical shift difference (obs*-pred) greater than  5.0ppm:
#NUM  AA    CS     Observed*    Predicted
#  2   T    C      175.80       170.21
# 56   A    C      176.31       182.07
#
#After reference correction, the following residues still 
#have a N chemical shift difference (obs*-pred) greater than 10.0ppm:
#NUM  AA    CS     Observed*    Predicted
#126   E    N      127.00       115.36
#
#The average CS difference between predicted and observed:
#HA       CA       CB      CO       N      HN
#0.11    -0.36   -0.08   -0.38   -0.50   -0.10   
#
#bmr5099.str.corr chemical shifts have been re-referenced with the following 
#offsets (these values have been added to the original bmr5099.str file):
#HA       CA       CB      CO       N      HN
#N/A    -0.22   -0.22   -0.38    -0.50     N/A
#
#The 95% confidence intervals for the above recommended offsets are:
#    HA       CA       CB       CO       N        HN
#+/-0.04  +/-0.17  +/-0.25  +/-0.20  +/-0.40  +/-0.07  
#
#The Correlation Coefficients between predicted and observed 
#chemical shifts are:
#HA       CA       CB      CO       N      HN
#0.835   0.946   0.996   0.619   0.825   0.672   
#
#The RMSD between predicted and observed* (reference 
#corrected) chemical shifts are:
#HA       CA       CB      CO       N       HN
#0.181   0.884   0.901   0.964   2.096   0.371   
#



#######################
#  Entry information  #
#######################

save_entry_information
   _Saveframe_category      entry_information

   _Entry_title            
;
Backbone and side chain 1H, 13C, and 15N Chemical Shift Assignments for N-TIMP-1
 in N-TIMP-1/MMP-3(E202Q) Complex
;

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

       1   Arumugam    S.      .   . 
       2  "Van Doren"  Steven  R.  . 

   stop_

   _BMRB_accession_number   5099
   _BMRB_flat_file_name     bmr5099.str
   _Entry_type              new
   _Submission_date         2001-08-03
   _Accession_date          2001-08-03
   _Entry_origination       author
   _NMR_STAR_version        2.1.1
   _Experimental_method     NMR

   loop_
      _Saveframe_category_type
      _Saveframe_category_type_count

       assigned_chemical_shifts  1  

   stop_

   loop_
      _Data_type
      _Data_type_count

      '1H chemical shifts'   392  
      '15N chemical shifts'  113  
      '13C chemical shifts'  327  

   stop_

   loop_
      _Revision_date
      _Revision_keyword
      _Revision_author
      _Revision_detail

       2003-05-20  update    author "correction of chemical shifts"      
       2003-05-20  update    author "addition of side chain assignmnets" 
       2002-08-22  original  author "original release"                   

   stop_

save_


#############################
#  Citation for this entry  #
#############################

save_entry_citation
   _Saveframe_category     entry_citation

   _Citation_title        
;
Increased backbone mobility in  Beta-barrel enhances entropy gain 
driving binding of N-TIMP-1 to MMP-3
;
   _Citation_status        published
   _Citation_type          journal
   _MEDLINE_UI_code        .
   _PubMed_ID              12634064

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

       1   Arumugam     S.      .   . 
       2   Gao          G.      .   . 
       3   Patton       B.      .   . 
       4   Semenchenko  V.      .   . 
       5   Brew         K.      .   . 
       6  "Van Doren"   Steven  R.  . 

   stop_

   _Journal_abbreviation  "J. Mol. Biol."
   _Journal_volume         327
   _Journal_issue          3
   _Page_first             719
   _Page_last              734
   _Year                   2003

   loop_
      _Keyword

      "TIMP-1/MMP-3(E202Q) complex"                   
      "tissue inhibitor of matrix metalloproteinases" 
      "NMR assignments"                               
      "matrix metalloproteinase-3"                    

   stop_

save_


##################################
#  Molecular system description  #
##################################

save_system_N-TIMP-1/MMP-3(deltaC)_complex
   _Saveframe_category         molecular_system

   _Mol_system_name           "N-terminus of Tissue Inhibitor of Metalloproteinases-1/Matrix MetalloProteinase-3(E202Q)(deltaC) complex"
   _Abbreviation_common       "N-TIMP-1/MMP-3(deltaC) complex"
   _Enzyme_commission_number   .

   loop_
      _Mol_system_component_name
      _Mol_label

      "N-TIMP-1, inhibitor"      $N-TIMP-1 
      "MMP-3, metalloproteinase" $MMP-3    
      'CALCIUM (II) ION'         $CA_2+    
      'ZINC (II) ION'            $ZN_2+    

   stop_

   _System_physical_state      native
   _System_oligomer_state      monomer
   _System_paramagnetic        no
   _System_thiol_state        'all disulfide bound'

   loop_
      _Biological_function

      "N-TIMP-1 inhibits the enzymatic activity of matrix metalloproteinases-1,-2, &-3 with Ki values less than 2.0 nM." 

   stop_

   loop_
      _Database_name
      _Database_accession_code
      _Database_entry_mol_name
      _Database_entry_details

       PDB  1UEA  ?                   
;
Present system contains only the N-terminal 2/3
of the Tissue Inhibitor of Metalloproteinase, 
whereas the related system is full-length.
In addition, the present system has been studied
in solution as a complex with a mutant matrix 
metalloproteinase-3(E202Q).
; 
       PDB  1D2B "free N-TIMP-1"       . 
       PDB  1UEA "MMP-3 bound TIMP-1" 
;
The present system has been studied
in solution as a complex with a mutant matrix 
metalloproteinase-3(E202Q).
; 

   stop_

   _Details                   
;
Present system contains only the N-terminal 2/3
of the Tissue Inhibitor of Metalloproteinase, 
whereas the related system is full-length.
In addition, the present system has been studied
in solution as a complex with a mutant matrix 
metalloproteinase-3(E202Q).
The system of PDB 1D2B has been studied
in solution as a complex with a mutant matrix 
metalloproteinase-3(E202Q).
;

save_


    ########################
    #  Monomeric polymers  #
    ########################

save_N-TIMP-1
   _Saveframe_category                          monomeric_polymer

   _Mol_type                                    polymer
   _Mol_polymer_class                           protein
   _Name_common                                "N-terminus of Tissue Inhibitor of Metalloproteinases-1/Matrix MetalloProteinases-3(catalytic domain) complex"
   _Name_variant                                .
   _Abbreviation_common                        "N-TIMP-1/MMP-3(deltaC) complex"
   _Mol_thiol_state                            'all disulfide bound'
   
   	##############################
   	#  Polymer residue sequence  #
   	##############################
   
   _Residue_count                               126
   _Mol_residue_sequence                       
;
CTCVPPHPQTAFCNSDLVIR
AKFVGTPEVNQTTLYQRYEI
KMTKMYKGFQALGDAADIRF
VYTPAMESVCGYFHRSHNRS
EEFLIAGKLQDGLLHITTCS
FVAPWNSLSLAQRRGFTKTY
TVGCEE
;

   loop_
      _Residue_seq_code
      _Residue_label

         1   CYS     2   THR     3   CYS     4   VAL     5   PRO 
         6   PRO     7   HIS     8   PRO     9   GLN    10   THR 
        11   ALA    12   PHE    13   CYS    14   ASN    15   SER 
        16   ASP    17   LEU    18   VAL    19   ILE    20   ARG 
        21   ALA    22   LYS    23   PHE    24   VAL    25   GLY 
        26   THR    27   PRO    28   GLU    29   VAL    30   ASN 
        31   GLN    32   THR    33   THR    34   LEU    35   TYR 
        36   GLN    37   ARG    38   TYR    39   GLU    40   ILE 
        41   LYS    42   MET    43   THR    44   LYS    45   MET 
        46   TYR    47   LYS    48   GLY    49   PHE    50   GLN 
        51   ALA    52   LEU    53   GLY    54   ASP    55   ALA 
        56   ALA    57   ASP    58   ILE    59   ARG    60   PHE 
        61   VAL    62   TYR    63   THR    64   PRO    65   ALA 
        66   MET    67   GLU    68   SER    69   VAL    70   CYS 
        71   GLY    72   TYR    73   PHE    74   HIS    75   ARG 
        76   SER    77   HIS    78   ASN    79   ARG    80   SER 
        81   GLU    82   GLU    83   PHE    84   LEU    85   ILE 
        86   ALA    87   GLY    88   LYS    89   LEU    90   GLN 
        91   ASP    92   GLY    93   LEU    94   LEU    95   HIS 
        96   ILE    97   THR    98   THR    99   CYS   100   SER 
       101   PHE   102   VAL   103   ALA   104   PRO   105   TRP 
       106   ASN   107   SER   108   LEU   109   SER   110   LEU 
       111   ALA   112   GLN   113   ARG   114   ARG   115   GLY 
       116   PHE   117   THR   118   LYS   119   THR   120   TYR 
       121   THR   122   VAL   123   GLY   124   CYS   125   GLU 
       126   GLU 

   stop_

   _Sequence_homology_query_date                2004-07-29
   _Sequence_homology_query_revised_last_date   2004-07-16

   loop_
      _Database_name
      _Database_accession_code
      _Database_entry_mol_name
      _Sequence_query_to_submitted_percentage
      _Sequence_subject_length
      _Sequence_identity
      _Sequence_positive
      _Sequence_homology_expectation_value

       PDB         1D2B        "A Chain A, The Mmp-Inhibitory, N-TerminalDomain Of Human Tissue Inhibitor Of Metalloproteinases-1(N-Timp-1), Solution Nmr, 29 Structures"                                                             100.00  126   100   100   4e-71 
       PDB         1OO9        "B Chain B, Orientation In Solution Of Mmp-3Catalytic Domain And N- Timp-1 From Residual DipolarCouplings"                                                                                             100.00  126   100   100   4e-71 
       PDB         1UEA        "B Chain B, Mmp-3TIMP-1 Complex"                                                                                                                                                                        68.48  184    98    98   3e-69 
       DBJ         BAA01913.1  "tissue inhibitor of metalloproteinases[Homo sapiens]"                                                                                                                                                  75.90  166    99    99   6e-58 
       EMBL        CAA26443.1  "unnamed protein product [Homo sapiens]"                                                                                                                                                                60.87  207   100   100   4e-71 
       EMBL        CAA26902.1  "unnamed protein product [Homo sapiens]"                                                                                                                                                                60.87  207   100   100   4e-71 
       EMBL        CAG28566.1  "TIMP1 [Homo sapiens]"                                                                                                                                                                                  60.87  207   100   100   4e-71 
       EMBL        CAG46779.1  "TIMP1 [Homo sapiens]"                                                                                                                                                                                  60.87  207   100   100   4e-71 
       GenBank     AAH07097.1  "TIMP1 protein [Homo sapiens]"                                                                                                                                                                          74.56  169   100   100   4e-71 
       GenBank     AAA52436.1  "prefibroblast collagenase inhibitor"                                                                                                                                                                   60.87  207   100   100   4e-71 
       GenBank     AAA63234.1  "collagenase inhibitor [Homo sapiens]"                                                                                                                                                                  60.87  207   100   100   4e-71 
       GenBank     AAA99943.1  "metalloprotease-1 tissue inhibitor"                                                                                                                                                                    60.87  207   100   100   4e-71 
       GenBank     AAD14009.1  "metalloproteinase inhibitor [Homosapiens]"                                                                                                                                                             60.87  207   100   100   4e-71 
       PIR         JC4303      "matrix metalloproteinase-1 tissue inhibitor- baboon"                                                                                                                                                   60.87  207   100   100   4e-71 
       PIR         ZYHUEP      "metalloproteinase tissue inhibitor 1 precursor[validated] - human"                                                                                                                                     60.87  207   100   100   4e-71 
       PRF         1107278A    "erythroid potentiating activity"                                                                                                                                                                       60.87  207   100   100   4e-71 
       PRF         1308125A    "metalloproteinase inhibitor"                                                                                                                                                                           60.87  207   100   100   4e-71 
       REF         NP_003245.1 "tissue inhibitor of metalloproteinase 1precursor; Erythroid-potentiating activity (tissueinhibitor of metalloproteinases); erythroid potentiatingactivity [Homo sapiens]"                              60.87  207   100   100   4e-71 
       SWISS-PROT  P01033      "TIM1_HUMAN Metalloproteinase inhibitor 1precursor (TIMP-1) (Erythroid potentiating activity)(EPA) (Tissue inhibitor of metalloproteinases)(Fibroblast collagenase inhibitor) (Collagenaseinhibitor)"   60.87  207   100   100   4e-71 
       SWISS-PROT  P49061      "TIM1_PAPCY Metalloproteinase inhibitor 1precursor (TIMP-1)"                                                                                                                                            60.87  207   100   100   4e-71 
       SWISS-PROT  Q95KL9      "TIM1_MACMU Metalloproteinase inhibitor 1precursor (TIMP-1)"                                                                                                                                            60.87  207    99    99   5e-70 

   stop_

save_


save_MMP-3
   _Saveframe_category                          monomeric_polymer

   _Mol_type                                    polymer
   _Mol_polymer_class                           protein
   _Name_common                                "Metalloproteinases-1/Matrix MetalloProteinase-3(catalytic domain, residue 83-255)"
   _Name_variant                                .
   _Abbreviation_common                        "N-TIMP-1/MMP-3(deltaC) complex"
   _Mol_thiol_state                            'not present'
   _Residue_count                               173
   _Mol_residue_sequence                       
;
FRTFPGIPKWRKTHLTYRIV
NYTPDLPKDAVDSAVEKALK
VWEEVTPLTFSRLYEGEADI
MISFAVREHGDFYPFDGPGN
VLAHAYAPGPGINGDAHFDD
DEQWTKDTTGTNLFLVAAHQ
IGHSLGLFHSANTEALMYPL
YHSLTDLTRFRLSQDDINGI
QSLYGPPPDSPET
;

   loop_
      _Residue_seq_code
      _Residue_label

         1   PHE     2   ARG     3   THR     4   PHE     5   PRO 
         6   GLY     7   ILE     8   PRO     9   LYS    10   TRP 
        11   ARG    12   LYS    13   THR    14   HIS    15   LEU 
        16   THR    17   TYR    18   ARG    19   ILE    20   VAL 
        21   ASN    22   TYR    23   THR    24   PRO    25   ASP 
        26   LEU    27   PRO    28   LYS    29   ASP    30   ALA 
        31   VAL    32   ASP    33   SER    34   ALA    35   VAL 
        36   GLU    37   LYS    38   ALA    39   LEU    40   LYS 
        41   VAL    42   TRP    43   GLU    44   GLU    45   VAL 
        46   THR    47   PRO    48   LEU    49   THR    50   PHE 
        51   SER    52   ARG    53   LEU    54   TYR    55   GLU 
        56   GLY    57   GLU    58   ALA    59   ASP    60   ILE 
        61   MET    62   ILE    63   SER    64   PHE    65   ALA 
        66   VAL    67   ARG    68   GLU    69   HIS    70   GLY 
        71   ASP    72   PHE    73   TYR    74   PRO    75   PHE 
        76   ASP    77   GLY    78   PRO    79   GLY    80   ASN 
        81   VAL    82   LEU    83   ALA    84   HIS    85   ALA 
        86   TYR    87   ALA    88   PRO    89   GLY    90   PRO 
        91   GLY    92   ILE    93   ASN    94   GLY    95   ASP 
        96   ALA    97   HIS    98   PHE    99   ASP   100   ASP 
       101   ASP   102   GLU   103   GLN   104   TRP   105   THR 
       106   LYS   107   ASP   108   THR   109   THR   110   GLY 
       111   THR   112   ASN   113   LEU   114   PHE   115   LEU 
       116   VAL   117   ALA   118   ALA   119   HIS   120   GLN 
       121   ILE   122   GLY   123   HIS   124   SER   125   LEU 
       126   GLY   127   LEU   128   PHE   129   HIS   130   SER 
       131   ALA   132   ASN   133   THR   134   GLU   135   ALA 
       136   LEU   137   MET   138   TYR   139   PRO   140   LEU 
       141   TYR   142   HIS   143   SER   144   LEU   145   THR 
       146   ASP   147   LEU   148   THR   149   ARG   150   PHE 
       151   ARG   152   LEU   153   SER   154   GLN   155   ASP 
       156   ASP   157   ILE   158   ASN   159   GLY   160   ILE 
       161   GLN   162   SER   163   LEU   164   TYR   165   GLY 
       166   PRO   167   PRO   168   PRO   169   ASP   170   SER 
       171   PRO   172   GLU   173   THR 

   stop_

   _Sequence_homology_query_date                2004-07-29
   _Sequence_homology_query_revised_last_date   2004-07-16

   loop_
      _Database_name
      _Database_accession_code
      _Database_entry_mol_name
      _Sequence_query_to_submitted_percentage
      _Sequence_subject_length
      _Sequence_identity
      _Sequence_positive
      _Sequence_homology_expectation_value

       PDB         1HFS        "Crystal Structure Of The Catalytic Domain OfHuman Fibroblast Stromelysin-1 Inhibited With TheN-Carboxy-Alkyl Inhibitor L-764,004"                                              108.13  160    99   100   10e-92  
       PDB         1QIC        "A Chain A, Crystal Structure Of StromelysinCatalytic Domain"                                                                                                                   107.45  161    99   100   2e-92   
       PDB         1QIA        "A Chain A, Crystal Structure Of StromelysinCatalytic Domain"                                                                                                                   106.79  162    99   100   3e-93   
       PDB         1USN        "Crystal Structure Of The Catalytic Domain OfHuman Fibroblast Stromelysin-1 Inhibited WithThiadiazole Inhibitor Pnu-142372"                                                     104.85  165    99   100   6e-95   
       PDB         2USN        "Crystal Structure Of The Catalytic Domain OfHuman Fibroblast Stromelysin-1 Inhibited WithThiadiazole Inhibitor Pnu-141803"                                                     104.85  165    99   100   6e-95   
       PDB         1C8T        "A Chain A, Human Stromelysin-1 (E202q)Catalytic Domain Complexed With Ro-26-2812"                                                                                              103.59  167   100   100   1e-96   
       PDB         1B8Y        "A Chain A, X-Ray Structure Of Human StromelysinCatalytic Domain Complexed With Non-Peptide Inhibitors:Implications For Inhibitor Selectivity"                                  103.59  167    99   100   1e-96   
       PDB         1CAQ        "A Chain A, X-Ray Structure Of Human StromelysinCatalytic Domain Complexes With Non-Peptide Inhibitors:Implication For Inhibitor Selectivity"                                   102.98  168    99   100   2e-97   
       PDB         1CIZ        "A Chain A, X-Ray Structure Of Human StromelysinCatalytic Domain Complexes With Non-Peptide Inhibitors:Implication For Inhibitor Selectivity"                                   102.98  168    99   100   2e-97   
       PDB         1G4K        "A Chain A, X-Ray Structure Of A Novel MatrixMetalloproteinase Inhibitor Complexed To Stromelysin"                                                                              102.98  168    99   100   2e-97   
       PDB         1OO9        "A Chain A, Orientation In Solution Of Mmp-3Catalytic Domain And N- Timp-1 From Residual DipolarCouplings"                                                                      102.98  168    99   100   2e-97   
       PDB         3USN        "Structure Of The Catalytic Domain Of HumanFibroblast Stromelysin-1 Inhibited With The ThiadiazoleInhibitor Ipnu-107859, Nmr, 1 Structure"                                      102.98  168    99   100   2e-97   
       PDB         1B3D        "A Chain A, Stromelysin-1"                                                                                                                                                      100.00  173    99   100   10e-101 
       PDB         1BIW        "A Chain A, Design And Synthesis OfConformationally-Constrained Mmp Inhibitors"                                                                                                 100.00  173    99   100   10e-101 
       PDB         1BM6        "Solution Structure Of The Catalytic Domain OfHuman Stromelysin-1 Complexed To A Potent Non-PeptidicInhibitor, Nmr, 20 Structures"                                              100.00  173    99   100   10e-101 
       PDB         1BQO        "A Chain A, Discovery Of Potent, Achiral MatrixMetalloproteinase Inhibitors"                                                                                                    100.00  173    99   100   10e-101 
       PDB         1C3I        "A Chain A, Human Stromelysin-1 Catalytic DomainComplexed With Ro-26- 2812"                                                                                                     100.00  173    99   100   10e-101 
       PDB         1CQR        "A Chain A, Crystal Structure Of The StromelysinCatalytic Domain At 2.0 A Resolution"                                                                                           100.00  173    99   100   10e-101 
       PDB         1D5J        "A Chain A, Crystal Structure Of Mmp3 ComplexedWith A Thiazepine Based Inhibitor."                                                                                              100.00  173    99   100   10e-101 
       PDB         1D7X        "A Chain A, Crystal Structure Of Mmp3 ComplexedWith A Modified Proline Scaffold Based Inhibitor."                                                                               100.00  173    99   100   10e-101 
       PDB         1D8F        "A Chain A, Crystal Structure Of Mmp3 ComplexedWith A Piperazine Based Inhibitor."                                                                                              100.00  173    99   100   10e-101 
       PDB         1D8M        "A Chain A, Crystal Structure Of Mmp3 ComplexedWith A Heterocycle- Based Inhibitor"                                                                                             100.00  173    99   100   10e-101 
       PDB         1G05        "A Chain A, Heterocycle-Based Mmp InhibitorWith P2'substituents"                                                                                                                100.00  173    99   100   10e-101 
       PDB         1G49        "A Chain A, A Carboxylic Acid Based InhibitorIn Complex With Mmp3"                                                                                                              100.00  173    99   100   10e-101 
       PDB         1HY7        "A Chain A, A Carboxylic Acid Based InhibitorIn Complex With Mmp3"                                                                                                              100.00  173    99   100   10e-101 
       PDB         1SLN        "Crystal Structure Of The Catalytic Domain OfHuman Fibroblast Stromelysin-1 Inhibited With TheN-Carboxy-Alkyl Inhibitor L-702,842"                                              100.00  173    99   100   10e-101 
       PDB         2SRT        "Catalytic Domain Of Human Stromelysin-1 At Ph5.5 And 40oc Complexed With Inhibitor"                                                                                            100.00  173    99   100   10e-101 
       PDB         1UEA        "A Chain A, Mmp-3TIMP-1 Complex"                                                                                                                                                100.00  173    98    99   4e-99   
       PDB         1UMS        "A Chain A, Stromelysin-1 Catalytic Domain WithHydrophobic Inhibitor Bound, Ph 7.0, 32oc, 20 Mm Cacl2,15% Acetonitrile; Nmr Ensemble Of 20 Structures"                           99.43  174    99   100   10e-101 
       PDB         1UMT        "A Chain A, Stromelysin-1 Catalytic Domain WithHydrophobic Inhibitor Bound, Ph 7.0, 32oc, 20 Mm Cacl2,15% Acetonitrile; Nmr Average Of 20 Structures MinimizedWith Restraints"   99.43  174    99   100   10e-101 
       PDB         1SLM        "Crystal Structure Of FibroblastStromelysin-1: The C-Truncated Human Proenzyme"                                                                                                  67.84  255    99   100   10e-101 
       EMBL        CAA28859.1  "preprostromelysin [Homo sapiens]"                                                                                                                                               36.27  477    99   100   10e-101 
       GenBank     AAD45887.1  "stromelysin catalytic domain [syntheticconstruct]"                                                                                                                              99.43  174    99   100   10e-101 
       GenBank     AAA00036.1  "prostromelysin=matrix metalloproteinase[human, Peptide, 477 aa]"                                                                                                                36.27  477    99   100   10e-101 
       GenBank     AAA36321.1  "matrix metalloproteinase-3"                                                                                                                                                     36.27  477    99   100   10e-101 
       GenBank     AAB36942.1  "stromelysin [Homo sapiens]"                                                                                                                                                     36.27  477    99   100   10e-101 
       GenBank     AAH69676.1  "Matrix metalloproteinase 3,preproprotein [Homo sapiens]"                                                                                                                        36.27  477    99   100   10e-101 
       PIR         KCHUS1      "stromelysin 1 (EC 3.4.24.17) precursor[validated] - human"                                                                                                                      36.27  477    99   100   10e-101 
       REF         NP_002413.1 "matrix metalloproteinase 3preproprotein; stromelysin 1; progelatinase; transin-1;proteoglycanase [Homo sapiens]"                                                                36.27  477    99   100   10e-101 
       SWISS-PROT  P08254      "MM03_HUMAN Stromelysin-1 precursor (Matrixmetalloproteinase-3) (MMP-3) (Transin-1) (SL-1)"                                                                                      36.27  477    99   100   10e-101 

   stop_

save_


    #############
    #  Ligands  #
    #############

save_CA_2+
   _Saveframe_category      ligand

   _Mol_type                non-polymer
   _Name_common            'CALCIUM (II) ION'
   _Abbreviation_common     Ca
   _Name_IUPAC              .
   _BMRB_code               CA_2+
   _PDB_code                CA
   _Mol_empirical_formula   CA1
   _Mol_charge              2+
   _Mol_paramagnetic        no
   _Mol_aromatic            no
   _Details                 .

   loop_
      _Atom_name
      _PDB_atom_name
      _Atom_type
      _Atom_chirality
      _Atom_charge
      _Atom_oxidation_number
      _Atom_unpaired_electrons

       CA  CA  CA  ?  2+  ?  ? 

   stop_

save_


save_ZN_2+
   _Saveframe_category      ligand

   _Mol_type                non-polymer
   _Name_common            'ZINC (II) ION'
   _Abbreviation_common     Zn
   _Name_IUPAC              .
   _BMRB_code               ZN_2+
   _PDB_code                ZN
   _Mol_empirical_formula   Zn1
   _Mol_charge              2+
   _Mol_paramagnetic        no
   _Mol_aromatic            no
   _Details                 .

   loop_
      _Atom_name
      _PDB_atom_name
      _Atom_type
      _Atom_chirality
      _Atom_charge
      _Atom_oxidation_number
      _Atom_unpaired_electrons

       ZN  ZN  ZN  ?  2+  ?  ? 

   stop_

save_


    ###################################################
    #  Biologically functional molecule descriptions  #
    ###################################################

save_biol_func_N-TIMP-1/MMP-3(deltaC)_complex
   _Saveframe_category         biol_func_molecular_system

   _Abbreviation_common       "N-TIMP-1/MMP-3(deltaC) complex"
   _Enzyme_commission_number   3.4.24.17
   _Details                   
;
Family of MMP is known to have been 
involved in tissue remodeling of cancer,
arthritis and numerous tissue degenerative
diseases.
;

   loop_
      _Database_name
      _Database_entry_details

       PDB 
      
;
In the present system, MMP-3 has been 
mutated to E202Q but the enzyme still
maintains the enzymatic activity.
; 
      

   stop_

save_


    ########################################
    #  Molecular bond linkage definitions  #
    ########################################

save_crosslink_bonds
   _Saveframe_category   crosslink_bonds


   loop_
      _Bond_order
      _Bond_type
      _Atom_one_mol_system_component_name
      _Atom_one_residue_seq_code
      _Atom_one_residue_label
      _Atom_one_atom_name
      _Atom_two_mol_system_component_name
      _Atom_two_residue_seq_code
      _Atom_two_residue_label
      _Atom_two_atom_name

       single  disulfide "N-TIMP-1, inhibitor"   1   CYS  SG "N-TIMP-1, inhibitor"   70   CYS  SG 
       single  disulfide "N-TIMP-1, inhibitor"   3   CYS  SG "N-TIMP-1, inhibitor"   99   CYS  SG 
       single  disulfide "N-TIMP-1, inhibitor"  13   CYS  SG "N-TIMP-1, inhibitor"  124   CYS  SG 

   stop_

save_


    ####################
    #  Natural source  #
    ####################

save_natural_source
   _Saveframe_category   natural_source


   loop_
      _Mol_label
      _Organism_name_common
      _NCBI_taxonomy_ID
      _Superkingdom
      _Kingdom
      _Genus
      _Species

      $N-TIMP-1  Human  9606   Eukaryota  Metazoa  Homo  sapiens 
      $MMP-3     Human  9606   Eukaryota  Metazoa  Homo  sapiens 

   stop_

save_


    #########################
    #  Experimental source  #
    #########################

save_experimental_source
   _Saveframe_category   experimental_source


   loop_
      _Mol_label
      _Production_method
      _Host_organism_name_common
      _Genus
      _Species
      _Strain
      _Vector_type
      _Vector_name

      $N-TIMP-1 'recombinant technology' "E. coli"  Escherichia  coli "BL21 (DE3)" "T7 expression"  pET3a 
      $MMP-3    'recombinant technology' "E. coli"  Escherichia  coli "BL21 (DE3)" "T7 expression"  pET3a 

   stop_

save_


#####################################
#  Sample contents and methodology  #
#####################################
	 
    ########################
    #  Sample description  #
    ########################

save_sample_1
   _Saveframe_category   sample

   _Sample_type          solution

   loop_
      _Mol_label
      _Concentration_value
      _Concentration_value_units
      _Isotopic_labeling

      $N-TIMP-1    0.66  mM "[U-13C; U-15N]" 
      $MMP-3       0.66  mM  .               
       Tris       20     mM "[U-2H]"         
       NaCl      125     mM  .               
       CaCl2      10     mM  .               
       NaN3        1     mM  .               
       ZnCl2      50     uM  .               
       D2O         7     %   .               
       H2O        93     %   .               

   stop_

save_


save_sample_2
   _Saveframe_category   sample

   _Sample_type          solution

   loop_
      _Mol_label
      _Concentration_value
      _Concentration_value_units
      _Isotopic_labeling

      $N-TIMP-1    0.52  mM "[U-50% 2H; U-13C; U-15N]" 
      $MMP-3       0.52  mM  .                         
       Tris       20     mM "[U-2H]"                   
       NaCl      125     mM  .                         
       CaCl2      10     mM  .                         
       NaN3        1     mM  .                         
       ZnCl2      50     uM  .                         
       D2O         7     %   .                         
       H2O        93     %   .                         

   stop_

save_


save_sample_3
   _Saveframe_category   sample

   _Sample_type          solution

   loop_
      _Mol_label
      _Concentration_value
      _Concentration_value_units
      _Isotopic_labeling

      $N-TIMP-1    0.30  mM "[U-2H; U-13C; U-15N]" 
      $MMP-3       0.30  mM  .                     
       Tris       20     mM "[U-2H]"               
       NaCl      125     mM  .                     
       CaCl2      10     mM  .                     
       NaN3        1     mM  .                     
       ZnCl2      50     uM  .                     
       D2O         7     %   .                     
       H2O        93     %   .                     

   stop_

save_


############################
#  Computer software used  #
############################

save_SYBYL_TRIAD
   _Saveframe_category   software

   _Name                "SYBYL TRIAD"
   _Version             "6.2, 6.3, 6.6"

   loop_
      _Task

      "process NMR spectra"   
      "interpret NMR spectra" 

   stop_

   _Details             
;
At times, use of NMRPIPE software for
an intermediate data conversion was 
necessary before processing with Sybyl.
;

save_


#########################
#  Experimental detail  #
#########################

    ##################################
    #  NMR Spectrometer definitions  #
    ##################################

save_NMR_spectrometer_1
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Bruker
   _Model                DRX
   _Field_strength       750

save_


save_NMR_spectrometer_2
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Bruker
   _Model                DRX
   _Field_strength       500

save_


save_NMR_spectrometer_3
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Varian
   _Model                Inova
   _Field_strength       600

save_


save_NMR_spectrometer_4
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Varian
   _Model                UnityPlus
   _Field_strength       720

save_


    #############################
    #  NMR applied experiments  #
    #############################

save_NMR_applied_experiment
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name     
;
2D 15N HSQC
3D HNCA
3D HN(CO)CA
3D HNCO
3D TROSY-HNCA
NOESY-HSQC
;

save_


#######################
#  Sample conditions  #
#######################

save_EX-COND-1
   _Saveframe_category   sample_conditions


   loop_
      _Variable_type
      _Variable_value
      _Variable_value_error
      _Variable_value_units

       pH                 6.22   0.05  n/a 
       temperature      307      0.5   K   
      'ionic strength'    0.186  0.02  M   

   stop_

save_


####################
#  NMR parameters  #
####################

    ##############################
    #  Assigned chemical shifts  #
    ##############################

	################################
	#  Chemical shift referencing  #
	################################

save_chemical_shift_reference
   _Saveframe_category   chemical_shift_reference


   loop_
      _Mol_common_name
      _Atom_type
      _Atom_isotope_number
      _Atom_group
      _Chem_shift_units
      _Chem_shift_value
      _Reference_method
      _Reference_type
      _External_reference_sample_geometry
      _External_reference_location
      _External_reference_axis
      _Indirect_shift_ratio

       DSS  H   1  'methyl protons'  ppm  0.0  internal  direct    .  .  .  1.0         
       DSS  N  15  'methyl protons'  ppm  0.0  .         indirect  .  .  .  0.101329118 
       DSS  C  13  'methyl protons'  ppm  0.0  .         indirect  .  .  .  0.251449530 

   stop_

save_


	###################################
	#  Assigned chemical shift lists  #
	###################################

###################################################################
#       Chemical Shift Ambiguity Index Value Definitions          #
#                                                                 #
#   Index Value            Definition                             #
#                                                                 #
#      1             Unique                                       #
#      2             Ambiguity of geminal atoms or geminal methyl #
#                         proton groups                           #
#      3             Aromatic atoms on opposite sides of the ring #
#                        (e.g. Tyr HE1 and HE2 protons)           #
#      4             Intraresidue ambiguities (e.g. Lys HG and    #
#                         HD protons)                             #
#      5             Interresidue ambiguities (Lys 12 vs. Lys 27) #
#      9             Ambiguous, specific ambiguity not defined    #
#                                                                 #
###################################################################

save_timpcpxshifts08022001
   _Saveframe_category               assigned_chemical_shifts


   loop_
      _Sample_label

      $sample_1 

   stop_

   _Sample_conditions_label         $EX-COND-1
   _Chem_shift_reference_set_label  $chemical_shift_reference
   _Mol_system_component_name       "N-TIMP-1, inhibitor"

   loop_
      _Atom_shift_assign_ID
      _Residue_seq_code
      _Residue_label
      _Atom_name
      _Atom_type
      _Chem_shift_value
      _Chem_shift_value_error
      _Chem_shift_ambiguity_code

     1     1   CYS       C     C    176.72     0.12     1
     2     1   CYS       HB2   H      2.94     0.01     2
     3     2   THR       H     H      7.83     0.01     1
     4     2   THR       HG2   H      1.16     0.01     1
     5     2   THR       C     C    175.80     0.12     1
     6     2   THR       CA    C     62.46     0.12     1
     7     2   THR       N     N    127.89     0.12     1
     8     3   CYS       H     H      8.85     0.01     1
     9     3   CYS       HA    H      4.95     0.01     1
    10     3   CYS       HB2   H      3.46     0.01     2
    11     3   CYS       C     C    175.79     0.12     1
    12     3   CYS       CA    C     52.49     0.12     1
    13     3   CYS       N     N    124.49     0.12     1
    14     4   VAL       H     H      8.29     0.01     1
    15     4   VAL       HB    H      1.94     0.01     1
    16     4   VAL       HG1   H      1.10     0.01     1
    17     4   VAL       CA    C     62.24     0.12     1
    18     4   VAL       N     N    124.11     0.12     1
    19     6   PRO       HA    H      4.32     0.01     1
    20     6   PRO       CA    C     58.81     0.12     1
    21     7   HIS       H     H      8.31     0.01     1
    22     7   HIS       CA    C     55.21     0.12     1
    23     7   HIS       N     N    119.98     0.12     1
    24     8   PRO       C     C    176.20     0.12     1
    25     8   PRO       CA    C     66.17     0.12     1
    26     9   GLN       H     H      8.38     0.01     1
    27     9   GLN       HB2   H      2.55     0.01     9
    28     9   GLN       HB3   H      2.15     0.01     9
    29     9   GLN       HG2   H      1.90     0.01     2
    30     9   GLN       HG3   H      1.65     0.01     2
    31     9   GLN       C     C    177.91     0.12     1
    32     9   GLN       CA    C     58.97     0.12     1
    33     9   GLN       CG    C     33.65     0.12     1
    34     9   GLN       N     N    117.18     0.12     1
    35    10   THR       H     H      7.17     0.12     1
    36    10   THR       HA    H      3.66     0.01     1
    37    10   THR       HB    H      4.07     0.01     1
    38    10   THR       HG2   H      1.02     0.01     1
    39    10   THR       C     C    176.54     0.12     1
    40    10   THR       CA    C     65.56     0.12     1
    41    10   THR       CB    C     63.76     0.12     9
    42    10   THR       CG2   C     22.26     0.12     1
    43    10   THR       N     N    114.51     0.12     1
    44    11   ALA       H     H      8.72     0.01     1
    45    11   ALA       HA    H      3.89     0.01     1
    46    11   ALA       HB    H      1.32     0.01     1
    47    11   ALA       C     C    180.51     0.12     1
    48    11   ALA       CA    C     54.99     0.12     1
    49    11   ALA       CB    C     19.05     0.12     1
    50    11   ALA       N     N    123.61     0.12     1
    51    12   PHE       H     H      8.23     0.01     1
    52    12   PHE       C     C    176.66     0.12     1
    53    12   PHE       CA    C     62.40     0.12     1
    54    12   PHE       N     N    119.40     0.12     1
    55    13   CYS       H     H      7.92     0.01     1
    56    13   CYS       HA    H      4.26     0.01     1
    57    13   CYS       HB2   H      3.17     0.01     2
    58    13   CYS       HB3   H      2.66     0.01     2
    59    13   CYS       C     C    176.05     0.12     1
    60    13   CYS       CA    C     56.71     0.12     1
    61    13   CYS       CB    C     36.82     0.12     1
    62    13   CYS       N     N    114.07     0.12     1
    63    14   ASN       H     H      8.27     0.12     1
    64    14   ASN       HA    H      4.54     0.12     1
    65    14   ASN       HB2   H      2.67     0.01     2
    66    14   ASN       HB3   H      2.62     0.01     2
    67    14   ASN       C     C    175.44     0.12     1
    68    14   ASN       CA    C     54.02     0.12     1
    69    14   ASN       N     N    115.71     0.12     1
    70    15   SER       H     H      7.21     0.01     1
    71    15   SER       C     C    172.02     0.01     1
    72    15   SER       CA    C     59.82     0.12     1
    73    15   SER       N     N    115.73     0.12     1
    74    16   ASP       H     H      8.06     0.01     1
    75    16   ASP       HA    H      4.50     0.01     1
    76    16   ASP       HB2   H      2.27     0.01     2
    77    16   ASP       HB3   H      2.51     0.01     2
    78    16   ASP       C     C    175.09     0.12     1
    79    16   ASP       CA    C     56.39     0.12     1
    80    16   ASP       CB    C     43.18     0.12     1
    81    16   ASP       N     N    119.60     0.12     1
    82    17   LEU       H     H      7.41     0.01     1
    83    17   LEU       HA    H      4.57     0.01     1
    84    17   LEU       HB2   H      1.15     0.01     2
    85    17   LEU       HG    H      1.44     0.01     1
    86    17   LEU       HD1   H      0.70     0.01     2
    87    17   LEU       C     C    175.09     0.12     1
    88    17   LEU       CA    C     53.55     0.12     1
    89    17   LEU       CB    C     46.10     0.12     1
    90    17   LEU       CG    C     28.06     0.12     1
    91    17   LEU       CD1   C     25.68     0.12     2
    92    17   LEU       N     N    115.97     0.12     1
    93    18   VAL       H     H      8.21     0.01     1
    94    18   VAL       HA    H      5.01     0.01     1
    95    18   VAL       HB    H      1.85     0.01     1
    96    18   VAL       HG1   H      0.97     0.01     1
    97    18   VAL       HG2   H      0.65     0.01     1
    98    18   VAL       C     C    175.60     0.12     1
    99    18   VAL       CA    C     61.72     0.12     1
   100    18   VAL       CB    C     32.84     0.12     1
   101    18   VAL       CG1   C     22.49     0.12     1
   102    18   VAL       CG2   C     20.64     0.12     1
   103    18   VAL       N     N    121.47     0.12     1
   104    19   ILE       H     H      9.27     0.01     1
   105    19   ILE       HA    H      5.02     0.01     1
   106    19   ILE       HB    H      1.85     0.01     1
   107    19   ILE       HG2   H      0.73     0.01     1
   108    19   ILE       HD1   H      0.23     0.01     1
   109    19   ILE       C     C    173.12     0.12     1
   110    19   ILE       CA    C     58.99     0.12     1
   111    19   ILE       CB    C     42.12     0.12     1
   112    19   ILE       CG2   C     18.52     0.12     1
   113    19   ILE       CD1   C     13.79     0.12     1
   114    19   ILE       N     N    121.35     0.12     1
   115    20   ARG       H     H      8.87     0.01     1
   116    20   ARG       HA    H      5.42     0.01     1
   117    20   ARG       HB2   H      0.99     0.01     2
   118    20   ARG       HB3   H      1.55     0.01     2
   119    20   ARG       HG2   H      1.02     0.01     2
   120    20   ARG       HD2   H      1.40     0.01     2
   121    20   ARG       HD3   H      1.66     0.01     2
   122    20   ARG       C     C    176.02     0.12     1
   123    20   ARG       CA    C     54.31     0.12     1
   124    20   ARG       CB    C     33.63     0.12     1
   125    20   ARG       CG    C     26.21     0.12     1
   126    20   ARG       CD    C     43.71     0.12     1
   127    20   ARG       N     N    121.09     0.12     1
   128    21   ALA       H     H      9.49     0.01     1
   129    21   ALA       HA    H      4.96     0.01     1
   130    21   ALA       HB    H      0.73     0.01     1
   131    21   ALA       C     C    175.36     0.12     1
   132    21   ALA       CA    C     51.34     0.12     1
   133    21   ALA       CB    C     24.08     0.12     1
   134    21   ALA       N     N    124.33     0.12     1
   135    22   LYS       H     H      8.32     0.01     1
   136    22   LYS       HA    H      4.79     0.01     1
   137    22   LYS       HB2   H      1.19     0.01     2
   138    22   LYS       HG2   H      1.09     0.01     2
   139    22   LYS       HD2   H      1.71     0.01     9
   140    22   LYS       HE2   H      2.62     0.01     2
   141    22   LYS       HE3   H      2.67     0.01     2
   142    22   LYS       C     C    176.03     0.12     1
   143    22   LYS       CA    C     55.02     0.12     1
   144    22   LYS       CB    C     34.69     0.12     1
   145    22   LYS       CG    C     25.68     0.12     1
   146    22   LYS       N     N    118.68     0.12     1
   147    23   PHE       H     H      9.56     0.01     1
   148    23   PHE       HA    H      4.18     0.01     1
   149    23   PHE       HB2   H      2.40     0.01     2
   150    23   PHE       C     C    176.30     0.01     1
   151    23   PHE       CA    C     58.56     0.12     1
   152    23   PHE       N     N    124.36     0.12     1
   153    24   VAL       H     H      7.98     0.01     1
   154    24   VAL       HA    H      4.11     0.01     1
   155    24   VAL       HB    H      1.83     0.01     1
   156    24   VAL       HG1   H      0.58     0.01     1
   157    24   VAL       HG2   H      0.35     0.01     1
   158    24   VAL       C     C    175.72     0.12     1
   159    24   VAL       CA    C     62.06     0.12     1
   160    24   VAL       CB    C     32.57     0.12     1
   161    24   VAL       CG1   C     20.90     0.12     1
   162    24   VAL       CG2   C     18.78     0.12     1
   163    24   VAL       N     N    118.20     0.12     1
   164    25   GLY       H     H      8.20     0.01     1
   165    25   GLY       HA2   H      4.19     0.01     2
   166    25   GLY       HA3   H      3.96     0.01     2
   167    25   GLY       C     C    173.21     0.12     1
   168    25   GLY       CA    C     45.35     0.12     1
   169    25   GLY       N     N    109.34     0.12     1
   170    26   THR       H     H      8.31     0.01     1
   171    26   THR       HA    H      4.47     0.01     1
   172    26   THR       HB    H      4.10     0.01     1
   173    26   THR       HG2   H      1.10     0.01     1
   174    26   THR       CA    C     59.82     0.12     1
   175    26   THR       CB    C     68.91     0.12     1
   176    26   THR       CG2   C     20.90     0.12     1
   177    26   THR       N     N    116.06     0.12     1
   178    27   PRO       HA    H      4.13     0.01     1
   179    27   PRO       C     C    176.48     0.12     1
   180    27   PRO       CA    C     62.97     0.12     1
   181    28   GLU       H     H      8.41     0.01     1
   182    28   GLU       HA    H      4.38     0.01     1
   183    28   GLU       HB2   H      1.73     0.01     2
   184    28   GLU       HB3   H      1.67     0.01     2
   185    28   GLU       HG2   H      2.06     0.01     2
   186    28   GLU       HG3   H      1.85     0.01     2
   187    28   GLU       CA    C     54.71     0.12     1
   188    28   GLU       CB    C     31.53     0.12     1
   189    28   GLU       CG    C     35.60     0.12     1
   190    28   GLU       N     N    121.09     0.12     1
   191    29   VAL       H     H      8.85     0.01     1
   192    29   VAL       C     C    172.61     0.12     1
   193    29   VAL       N     N    127.26     0.12     1
   194    30   ASN       H     H      8.69     0.01     1
   195    30   ASN       HA    H      4.73     0.01     1
   196    30   ASN       HB2   H      2.58     0.01     9
   197    30   ASN       CA    C     52.04     0.12     1
   198    30   ASN       N     N    128.39     0.12     1
   199    31   GLN       H     H      9.64     0.01     1
   200    31   GLN       HB2   H      2.04     0.01     9
   201    31   GLN       HB3   H      1.81     0.01     2
   202    31   GLN       CB    C     28.06     0.12     9
   203    31   GLN       N     N    120.13     0.12     1
   204    32   THR       H     H      8.89     0.01     1
   205    32   THR       CA    C     64.73     0.12     1
   206    32   THR       N     N    115.30     0.12     1
   207    33   THR       H     H      7.60     0.01     1
   208    33   THR       N     N    111.57     0.12     1
   209    34   LEU       H     H      8.19     0.01     1
   210    34   LEU       N     N    116.06     0.12     1
   211    35   TYR       H     H      7.91     0.01     1
   212    35   TYR       C     C    174.78     0.12     1
   213    35   TYR       CA    C     58.29     0.12     1
   214    35   TYR       N     N    118.33     0.12     1
   215    36   GLN       H     H      9.85     0.01     1
   216    36   GLN       HA    H      5.16     0.01     1
   217    36   GLN       C     C    172.53     0.12     1
   218    36   GLN       CA    C     52.65     0.12     1
   219    36   GLN       N     N    119.46     0.12     1
   220    37   ARG       H     H      8.34     0.01     1
   221    37   ARG       HA    H      5.19     0.01     1
   222    37   ARG       HB2   H      0.73     0.01     2
   223    37   ARG       HB3   H      1.01     0.01     2
   224    37   ARG       HG2   H      0.63     0.01     2
   225    37   ARG       HG3   H      1.20     0.01     9
   226    37   ARG       HD2   H      1.50     0.01     2
   227    37   ARG       HD3   H      2.34     0.01     2
   228    37   ARG       C     C    174.14     0.12     1
   229    37   ARG       CA    C     53.04     0.12     1
   230    37   ARG       CD    C     43.25     0.12     1
   231    37   ARG       N     N    118.08     0.12     1
   232    38   TYR       H     H      9.07     0.01     1
   233    38   TYR       C     C    174.86     0.12     1
   234    38   TYR       CA    C     56.68     0.12     1
   235    38   TYR       N     N    121.59     0.12     1
   236    39   GLU       H     H      8.93     0.01     1
   237    39   GLU       HA    H      4.35     0.01     1
   238    39   GLU       HB2   H      1.68     0.01     2
   239    39   GLU       HB3   H      1.60     0.01     2
   240    39   GLU       HG2   H      1.74     0.01     2
   241    39   GLU       C     C    175.53     0.12     1
   242    39   GLU       CA    C     56.02     0.12     1
   243    39   GLU       N     N    125.49     0.12     1
   244    40   ILE       H     H      8.32     0.01     1
   245    40   ILE       HA    H      4.88     0.01     1
   246    40   ILE       HB    H      0.90     0.01     1
   247    40   ILE       HG12  H      0.77     0.01     2
   248    40   ILE       HG2   H     -0.36     0.01     1
   249    40   ILE       HD1   H     -0.02     0.01     1
   250    40   ILE       C     C    174.66     0.12     1
   251    40   ILE       CA    C     58.51     0.12     1
   252    40   ILE       CB    C     42.93     0.12     1
   253    40   ILE       CG1   C     24.62     0.12     9
   254    40   ILE       CG2   C     16.66     0.12     1
   255    40   ILE       CD1   C     14.54     0.12     1
   256    40   ILE       N     N    120.71     0.12     1
   257    41   LYS       H     H      8.56     0.01     1
   258    41   LYS       C     C    175.41     0.12     1
   259    41   LYS       CA    C     53.98     0.12     1
   260    41   LYS       N     N    120.71     0.12     1
   261    42   MET       H     H      9.30     0.12     1
   262    42   MET       C     C    175.90     0.12     1
   263    42   MET       CA    C     56.70     0.12     1
   264    42   MET       N     N    128.14     0.12     1
   265    43   THR       H     H      9.19     0.01     1
   266    43   THR       HA    H      4.14     0.01     1
   267    43   THR       HB    H      3.82     0.01     1
   268    43   THR       HG2   H      0.78     0.01     1
   269    43   THR       C     C    175.26     0.12     1
   270    43   THR       CA    C     62.02     0.12     1
   271    43   THR       CB    C     68.32     0.12     1
   272    43   THR       CG2   C     22.42     0.12     1
   273    43   THR       N     N    119.46     0.12     1
   274    44   LYS       H     H      7.30     0.01     1
   275    44   LYS       HA    H      4.03     0.01     1
   276    44   LYS       HB2   H      1.19     0.01     2
   277    44   LYS       HB3   H      0.76     0.01     2
   278    44   LYS       HG2   H      0.55     0.01     2
   279    44   LYS       HG3   H      0.67     0.01     2
   280    44   LYS       HD2   H      1.34     0.01     2
   281    44   LYS       HE2   H      2.68     0.01     2
   282    44   LYS       HE3   H      2.60     0.01     2
   283    44   LYS       C     C    172.97     0.12     1
   284    44   LYS       CA    C     55.63     0.12     1
   285    44   LYS       CB    C     35.93     0.12     1
   286    44   LYS       CG    C     24.05     0.12     1
   287    44   LYS       CD    C     27.79     0.12     1
   288    44   LYS       CE    C     41.95     0.12     1
   289    44   LYS       N     N    121.09     0.12     1
   290    45   MET       H     H      8.60     0.01     1
   291    45   MET       CA    C     55.39     0.12     1
   292    45   MET       N     N    124.61     0.12     1
   293    46   TYR       H     H      8.63     0.01     1
   294    46   TYR       HA    H      4.88     0.01     1
   295    46   TYR       HB2   H      3.75     0.01     9
   296    46   TYR       C     C    175.25     0.12     1
   297    46   TYR       CA    C     58.38     0.12     1
   298    46   TYR       N     N    123.08     0.12     1
   299    47   LYS       H     H      7.94     0.01     1
   300    47   LYS       CA    C     56.98     0.12     1
   301    47   LYS       N     N    120.84     0.12     1
   302    48   GLY       H     H      8.69     0.01     1
   303    48   GLY       C     C    173.05     0.12     1
   304    48   GLY       CA    C     45.54     0.12     1
   305    48   GLY       N     N    113.79     0.12     1
   306    49   PHE       H     H      7.49     0.01     1
   307    49   PHE       HA    H      4.01     0.01     1
   308    49   PHE       HB2   H      2.79     0.01     2
   309    49   PHE       HB3   H      3.06     0.01     2
   310    49   PHE       C     C    176.73     0.12     1
   311    49   PHE       CA    C     59.85     0.12     1
   312    49   PHE       CB    C     39.02     0.12     1
   313    49   PHE       N     N    119.01     0.12     1
   314    50   GLN       H     H      8.72     0.01     1
   315    50   GLN       CA    C     57.70     0.12     1
   316    50   GLN       N     N    117.64     0.12     1
   317    51   ALA       H     H      7.68     0.01     1
   318    51   ALA       HA    H      4.08     0.01     1
   319    51   ALA       HB    H      1.18     0.01     1
   320    51   ALA       CA    C     53.46     0.12     1
   321    51   ALA       CB    C     19.05     0.12     1
   322    51   ALA       N     N    121.97     0.12     1
   323    52   LEU       H     H      7.64     0.01     1
   324    52   LEU       HA    H      4.16     0.01     1
   325    52   LEU       HB2   H      1.45     0.01     2
   326    52   LEU       HG    H      1.40     0.01     1
   327    52   LEU       HD1   H      0.63     0.01     1
   328    52   LEU       HD2   H      0.69     0.01     1
   329    52   LEU       C     C    177.63     0.12     1
   330    52   LEU       CA    C     55.13     0.12     1
   331    52   LEU       CB    C     42.12     0.12     1
   332    52   LEU       CG    C     26.74     0.12     1
   333    52   LEU       CD1   C     23.02     0.12     1
   334    52   LEU       CD2   C     25.15     0.12     1
   335    52   LEU       N     N    116.19     0.12     1
   336    53   GLY       H     H      7.90     0.01     1
   337    53   GLY       HA2   H      3.99     0.01     2
   338    53   GLY       HA3   H      3.65     0.01     2
   339    53   GLY       C     C    173.84     0.12     1
   340    53   GLY       CA    C     45.66     0.12     1
   341    53   GLY       N     N    108.38     0.12     1
   342    54   ASP       H     H      8.24     0.01     1
   343    54   ASP       C     C    176.10     0.12     1
   344    54   ASP       CA    C     55.07     0.12     1
   345    54   ASP       N     N    120.45     0.12     1
   346    55   ALA       H     H      8.09     0.01     1
   347    55   ALA       HA    H      4.09     0.01     1
   348    55   ALA       HB    H      1.18     0.01     1
   349    55   ALA       C     C    176.60     0.12     1
   350    55   ALA       CA    C     52.19     0.12     1
   351    55   ALA       CB    C     19.05     0.12     1
   352    55   ALA       N     N    123.36     0.12     1
   353    56   ALA       H     H      7.70     0.01     1
   354    56   ALA       HA    H      4.07     0.01     1
   355    56   ALA       HB    H      1.12     0.01     1
   356    56   ALA       C     C    176.31     0.12     1
   357    56   ALA       CA    C     52.49     0.12     1
   358    56   ALA       CB    C     19.05     0.12     1
   359    56   ALA       N     N    121.41     0.12     1
   360    57   ASP       H     H      8.01     0.01     1
   361    57   ASP       HA    H      4.44     0.01     1
   362    57   ASP       HB2   H      2.51     0.01     2
   363    57   ASP       HB3   H      2.37     0.01     2
   364    57   ASP       C     C    174.99     0.12     1
   365    57   ASP       CA    C     54.02     0.12     1
   366    57   ASP       CB    C     41.32     0.12     1
   367    57   ASP       N     N    118.57     0.12     1
   368    58   ILE       H     H      7.58     0.01     1
   369    58   ILE       HA    H      3.97     0.01     1
   370    58   ILE       HB    H      1.64     0.01     1
   371    58   ILE       HG12  H      1.19     0.01     2
   372    58   ILE       HG13  H      1.03     0.01     2
   373    58   ILE       HG2   H      0.64     0.01     1
   374    58   ILE       HD1   H      0.55     0.01     1
   375    58   ILE       C     C    174.66     0.12     1
   376    58   ILE       CA    C     60.99     0.12     1
   377    58   ILE       CB    C     37.35     0.12     1
   378    58   ILE       CG1   C     26.74     0.12     1
   379    58   ILE       CG2   C     17.81     0.12     1
   380    58   ILE       N     N    123.15     0.12     1
   381    59   ARG       H     H      8.47     0.01     1
   382    59   ARG       HA    H      4.13     0.01     1
   383    59   ARG       HB2   H      1.26     0.01     2
   384    59   ARG       HG2   H      1.00     0.01     2
   385    59   ARG       HG3   H      1.18     0.01     2
   386    59   ARG       HD2   H      2.86     0.01     2
   387    59   ARG       C     C    173.98     0.12     1
   388    59   ARG       CA    C     55.80     0.12     1
   389    59   ARG       CB    C     32.35     0.12     1
   390    59   ARG       CG    C     27.14     0.12     1
   391    59   ARG       CD    C     43.09     0.12     1
   392    59   ARG       N     N    124.37     0.12     1
   393    60   PHE       H     H      7.14     0.01     1
   394    60   PHE       HA    H      5.45     0.01     1
   395    60   PHE       HB2   H      2.48     0.01     2
   396    60   PHE       HB3   H      2.26     0.01     2
   397    60   PHE       C     C    174.60     0.12     1
   398    60   PHE       CA    C     55.99     0.12     1
   399    60   PHE       CB    C     45.04     0.12     1
   400    60   PHE       N     N    113.66     0.12     1
   401    61   VAL       H     H      8.58     0.01     1
   402    61   VAL       HA    H      4.67     0.01     1
   403    61   VAL       HB    H      1.53     0.01     1
   404    61   VAL       HG1   H      0.56     0.01     1
   405    61   VAL       C     C    173.23     0.12     1
   406    61   VAL       CA    C     59.84     0.12     1
   407    61   VAL       CB    C     34.43     0.12     1
   408    61   VAL       CG1   C     21.70     0.12     1
   409    61   VAL       N     N    116.22     0.12     1
   410    62   TYR       H     H      9.25     0.01     1
   411    62   TYR       HA    H      5.06     0.01     1
   412    62   TYR       C     C    174.94     0.12     1
   413    62   TYR       CA    C     57.67     0.12     1
   414    62   TYR       N     N    125.33     0.12     1
   415    63   THR       H     H      9.04     0.01     1
   416    63   THR       HA    H      5.30     0.01     9
   417    63   THR       HG2   H      1.42     0.01     1
   418    63   THR       CA    C     59.84     0.12     1
   419    63   THR       CG2   C     19.84     0.12     1
   420    63   THR       N     N    114.28     0.12     1
   421    65   ALA       HA    H      3.74     0.01     1
   422    65   ALA       HB    H      0.91     0.01     1
   423    65   ALA       CA    C     52.99     0.12     9
   424    65   ALA       CB    C     18.78     0.12     1
   425    66   MET       HB2   H      2.10     0.01     2
   426    68   SER       HA    H      5.02     0.01     1
   427    68   SER       HB2   H      3.72     0.01     2
   428    69   VAL       HA    H      4.40     0.01     1
   429    69   VAL       HB    H      2.57     0.01     1
   430    69   VAL       HG1   H      0.04     0.01     1
   431    69   VAL       HG2   H     -0.39     0.01     1
   432    69   VAL       C     C    173.67     0.12     1
   433    70   CYS       H     H      7.83     0.01     1
   434    70   CYS       C     C    176.05     0.12     1
   435    70   CYS       N     N    109.41     0.12     1
   436    71   GLY       H     H      8.15     0.01     1
   437    71   GLY       C     C    172.07     0.12     1
   438    71   GLY       N     N    109.91     0.12     1
   439    72   TYR       H     H      8.85     0.01     1
   440    72   TYR       C     C    173.81     0.12     1
   441    72   TYR       CA    C     58.54     0.12     1
   442    72   TYR       N     N    124.49     0.12     1
   443    73   PHE       H     H      8.00     0.01     1
   444    73   PHE       C     C    172.89     0.12     1
   445    73   PHE       CA    C     56.64     0.12     1
   446    73   PHE       N     N    130.22     0.12     1
   447    74   HIS       H     H      7.28     0.01     1
   448    74   HIS       HA    H      3.30     0.01     1
   449    74   HIS       HB2   H      1.67     0.01     2
   450    74   HIS       HB3   H      2.53     0.01     2
   451    74   HIS       C     C    175.64     0.12     1
   452    74   HIS       CA    C     56.68     0.12     1
   453    74   HIS       CB    C     32.35     0.12     1
   454    74   HIS       N     N    125.02     0.12     1
   455    75   ARG       H     H      7.81     0.01     1
   456    75   ARG       HA    H      3.98     0.01     1
   457    75   ARG       HB2   H      1.56     0.01     2
   458    75   ARG       HB3   H      1.52     0.01     2
   459    75   ARG       HG2   H      1.29     0.01     2
   460    75   ARG       HG3   H      1.23     0.01     2
   461    75   ARG       HD2   H      2.89     0.01     2
   462    75   ARG       C     C    174.99     0.12     1
   463    75   ARG       CA    C     55.74     0.12     1
   464    75   ARG       CB    C     30.23     0.12     1
   465    75   ARG       CG    C     26.81     0.12     1
   466    75   ARG       CD    C     42.92     0.12     1
   467    75   ARG       N     N    126.38     0.12     1
   468    76   SER       H     H      6.61     0.01     1
   469    76   SER       HA    H      4.13     0.01     1
   470    76   SER       HB2   H      3.62     0.01     2
   471    76   SER       HB3   H      3.17     0.01     2
   472    76   SER       CB    C     63.60     0.12     1
   473    76   SER       N     N    112.98     0.12     1
   474    77   HIS       CA    C     55.47     0.12     1
   475    78   ASN       H     H      8.18     0.01     1
   476    78   ASN       HA    H      4.71     0.01     1
   477    78   ASN       HB2   H      2.85     0.01     2
   478    78   ASN       HB3   H      2.59     0.01     2
   479    78   ASN       CA    C     52.45     0.12     1
   480    78   ASN       CB    C     38.41     0.12     1
   481    78   ASN       N     N    118.72     0.12     1
   482    79   ARG       H     H      8.83     0.01     1
   483    79   ARG       HA    H      4.18     0.01     1
   484    79   ARG       HB2   H      1.84     0.01     2
   485    79   ARG       HB3   H      1.74     0.01     2
   486    79   ARG       HG2   H      1.62     0.01     2
   487    79   ARG       HD2   H      3.06     0.01     2
   488    79   ARG       C     C    177.59     0.12     1
   489    79   ARG       CA    C     58.56     0.12     1
   490    79   ARG       CB    C     29.65     0.12     1
   491    79   ARG       CD    C     43.18     0.12     1
   492    79   ARG       N     N    124.47     0.12     1
   493    80   SER       H     H      8.28     0.01     1
   494    80   SER       HA    H      4.26     0.01     1
   495    80   SER       HB2   H      3.78     0.01     2
   496    80   SER       C     C    173.77     0.12     1
   497    80   SER       CA    C     59.17     0.12     1
   498    80   SER       CB    C     63.87     0.12     1
   499    80   SER       N     N    113.92     0.12     1
   500    81   GLU       H     H      7.49     0.01     1
   501    81   GLU       HA    H      4.01     0.01     1
   502    81   GLU       HB2   H      2.11     0.01     2
   503    81   GLU       HB3   H      2.03     0.01     2
   504    81   GLU       HG2   H      1.92     0.01     2
   505    81   GLU       C     C    175.87     0.12     1
   506    81   GLU       CA    C     56.83     0.12     1
   507    81   GLU       CG    C     35.76     0.12     1
   508    81   GLU       N     N    122.85     0.12     1
   509    82   GLU       H     H      8.88     0.01     1
   510    82   GLU       HG2   H      2.10     0.01     2
   511    82   GLU       HG3   H      1.65     0.01     2
   512    82   GLU       C     C    176.89     0.12     1
   513    82   GLU       CA    C     56.74     0.12     1
   514    82   GLU       CG    C     37.72     0.12     1
   515    82   GLU       N     N    123.86     0.12     1
   516    83   PHE       H     H      9.90     0.01     1
   517    83   PHE       C     C    173.47     0.12     1
   518    83   PHE       CA    C     57.82     0.12     1
   519    83   PHE       N     N    124.74     0.12     1
   520    84   LEU       H     H      9.60     0.01     1
   521    84   LEU       HA    H      4.91     0.01     1
   522    84   LEU       HB2   H      1.50     0.01     2
   523    84   LEU       HD2   H      0.41     0.01     1
   524    84   LEU       C     C    175.29     0.12     1
   525    84   LEU       CA    C     52.58     0.12     1
   526    84   LEU       CD2   C     23.39     0.12     1
   527    84   LEU       N     N    125.87     0.12     1
   528    85   ILE       H     H      9.31     0.01     1
   529    85   ILE       C     C    172.89     0.12     1
   530    85   ILE       CA    C     61.42     0.12     1
   531    85   ILE       N     N    124.49     0.12     1
   532    86   ALA       H     H      7.98     0.01     1
   533    86   ALA       HA    H      5.33     0.01     1
   534    86   ALA       HB    H      1.42     0.01     1
   535    86   ALA       C     C    176.03     0.12     1
   536    86   ALA       CA    C     50.58     0.12     1
   537    86   ALA       CB    C     19.84     0.12     1
   538    86   ALA       N     N    132.16     0.12     1
   539    87   GLY       H     H      8.55     0.01     1
   540    87   GLY       HA2   H      4.97     0.01     1
   541    87   GLY       HA3   H      3.43     0.01     1
   542    87   GLY       C     C    172.59     0.12     1
   543    87   GLY       CA    C     44.77     0.12     1
   544    87   GLY       N     N    106.24     0.12     1
   545    88   LYS       H     H      8.50     0.01     1
   546    88   LYS       HA    H      4.70     0.01     1
   547    88   LYS       HB2   H      1.60     0.01     2
   548    88   LYS       HG2   H      1.37     0.01     2
   549    88   LYS       HG3   H      1.39     0.01     2
   550    88   LYS       HD2   H      1.58     0.01     2
   551    88   LYS       HE2   H      2.87     0.01     2
   552    88   LYS       C     C    174.98     0.12     1
   553    88   LYS       CA    C     54.26     0.12     1
   554    88   LYS       CB    C     35.44     0.12     1
   555    88   LYS       CG    C     24.62     0.12     1
   556    88   LYS       CD    C     28.33     0.12     1
   557    88   LYS       CE    C     41.79     0.12     1
   558    88   LYS       N     N    120.34     0.12     1
   559    89   LEU       H     H      9.83     0.01     1
   560    89   LEU       HA    H      4.92     0.01     1
   561    89   LEU       HB2   H      1.30     0.01     2
   562    89   LEU       HG    H      1.21     0.01     1
   563    89   LEU       HD1   H      0.49     0.01     1
   564    89   LEU       HD2   H      0.55     0.01     1
   565    89   LEU       C     C    176.89     0.12     1
   566    89   LEU       CA    C     53.95     0.12     1
   567    89   LEU       CB    C     43.18     0.12     1
   568    89   LEU       CD1   C     23.55     0.12     1
   569    89   LEU       CD2   C     24.61     0.12     1
   570    89   LEU       N     N    124.87     0.12     1
   571    90   GLN       H     H      9.21     0.01     1
   572    90   GLN       HA    H      4.31     0.01     1
   573    90   GLN       HB2   H      1.34     0.01     2
   574    90   GLN       HG2   H      1.74     0.01     1
   575    90   GLN       C     C    175.17     0.12     1
   576    90   GLN       CA    C     55.08     0.12     1
   577    90   GLN       CB    C     30.18     0.12     1
   578    90   GLN       CG    C     33.00     0.12     1
   579    90   GLN       N     N    124.74     0.12     1
   580    91   ASP       H     H      9.30     0.01     1
   581    91   ASP       HA    H      4.18     0.01     1
   582    91   ASP       HB2   H      2.62     0.01     2
   583    91   ASP       HB3   H      2.36     0.01     2
   584    91   ASP       C     C    175.32     0.12     1
   585    91   ASP       CA    C     55.63     0.12     1
   586    91   ASP       CB    C     39.67     0.12     1
   587    91   ASP       N     N    128.14     0.12     1
   588    92   GLY       H     H      8.35     0.01     1
   589    92   GLY       HA2   H      3.89     0.01     2
   590    92   GLY       HA3   H      3.28     0.01     2
   591    92   GLY       C     C    172.65     0.12     1
   592    92   GLY       CA    C     45.41     0.12     1
   593    92   GLY       N     N    102.22     0.12     1
   594    93   LEU       H     H      7.66     0.01     1
   595    93   LEU       HA    H      4.47     0.01     1
   596    93   LEU       HB2   H      1.37     0.01     2
   597    93   LEU       HB3   H      0.87     0.01     2
   598    93   LEU       HG    H      1.26     0.01     1
   599    93   LEU       HD1   H      0.49     0.01     1
   600    93   LEU       HD2   H     -0.01     0.01     1
   601    93   LEU       CA    C     53.18     0.12     1
   602    93   LEU       CG    C     25.68     0.12     1
   603    93   LEU       CD1   C     21.70     0.12     1
   604    93   LEU       CD2   C     23.29     0.12     1
   605    93   LEU       N     N    120.84     0.12     1
   606    94   LEU       H     H      9.46     0.01     1
   607    94   LEU       HA    H      4.53     0.01     9
   608    94   LEU       HB2   H      1.06     0.01     9
   609    94   LEU       HB3   H      1.00     0.01     9
   610    94   LEU       HG    H      1.30     0.01     1
   611    94   LEU       HD1   H      0.66     0.01     1
   612    94   LEU       HD2   H      0.53     0.01     1
   613    94   LEU       C     C    174.16     0.12     1
   614    94   LEU       CA    C     55.59     0.12     1
   615    94   LEU       CG    C     27.33     0.12     1
   616    94   LEU       CD1   C     23.29     0.12     1
   617    94   LEU       CD2   C     25.68     0.12     1
   618    94   LEU       N     N    126.25     0.12     1
   619    95   HIS       H     H      9.78     0.01     1
   620    95   HIS       HA    H      5.49     0.01     1
   621    95   HIS       HB2   H      3.00     0.01     2
   622    95   HIS       C     C    176.42     0.12     1
   623    95   HIS       CA    C     56.13     0.12     1
   624    95   HIS       N     N    128.64     0.12     1
   625    96   ILE       H     H      9.02     0.01     1
   626    96   ILE       HA    H      4.99     0.01     1
   627    96   ILE       HB    H      1.75     0.01     1
   628    96   ILE       C     C    176.69     0.12     1
   629    96   ILE       CA    C     59.82     0.12     1
   630    96   ILE       N     N    113.16     0.12     1
   631    97   THR       H     H      9.62     0.01     1
   632    97   THR       C     C    176.28     0.12     1
   633    97   THR       CA    C     61.49     0.12     1
   634    97   THR       N     N    114.17     0.12     1
   635    98   THR       H     H      8.91     0.01     1
   636    98   THR       C     C    172.50     0.12     1
   637    98   THR       CA    C     66.14     0.12     1
   638    98   THR       N     N    116.06     0.12     1
   639    99   CYS       H     H      8.48     0.01     1
   640    99   CYS       C     C    175.70     0.12     1
   641    99   CYS       N     N    113.82     0.12     1
   642   100   SER       H     H      7.84     0.01     1
   643   100   SER       C     C    172.55     0.12     1
   644   100   SER       CA    C     59.49     0.12     1
   645   100   SER       N     N    118.59     0.12     1
   646   101   PHE       H     H      9.72     0.01     1
   647   101   PHE       C     C    171.99     0.12     1
   648   101   PHE       CA    C     59.66     0.12     1
   649   101   PHE       N     N    127.13     0.12     1
   650   102   VAL       H     H      7.01     0.01     1
   651   102   VAL       HA    H      4.93     0.01     1
   652   102   VAL       HB    H      1.61     0.01     1
   653   102   VAL       HG1   H      0.52     0.01     1
   654   102   VAL       HG2   H      0.40     0.01     1
   655   102   VAL       C     C    175.74     0.12     1
   656   102   VAL       CA    C     60.83     0.12     1
   657   102   VAL       CB    C     34.69     0.12     1
   658   102   VAL       CG1   C     20.37     0.12     1
   659   102   VAL       CG2   C     21.17     0.12     1
   660   102   VAL       N     N    128.77     0.12     1
   661   103   ALA       H     H      8.75     0.01     1
   662   103   ALA       HA    H      4.83     0.01     1
   663   103   ALA       HB    H      0.85     0.01     1
   664   103   ALA       CA    C     50.05     0.12     1
   665   103   ALA       CB    C     21.43     0.12     1
   666   103   ALA       N     N    127.76     0.12     1
   667   104   PRO       C     C    178.55     0.12     1
   668   104   PRO       CA    C     62.62     0.12     1
   669   105   TRP       H     H      8.99     0.01     1
   670   105   TRP       C     C    176.74     0.12     1
   671   105   TRP       CA    C     60.25     0.12     1
   672   105   TRP       N     N    130.65     0.12     1
   673   106   ASN       H     H      9.06     0.01     1
   674   106   ASN       HA    H      4.16     0.01     1
   675   106   ASN       HB2   H      2.55     0.01     2
   676   106   ASN       HB3   H      2.68     0.01     2
   677   106   ASN       C     C    175.62     0.12     1
   678   106   ASN       CA    C     54.56     0.12     1
   679   106   ASN       CB    C     37.39     0.12     1
   680   106   ASN       N     N    112.16     0.12     1
   681   107   SER       H     H      7.58     0.01     1
   682   107   SER       HA    H      4.22     0.01     1
   683   107   SER       HB2   H      3.67     0.01     2
   684   107   SER       HB3   H      3.79     0.01     2
   685   107   SER       C     C    174.09     0.12     1
   686   107   SER       CA    C     59.19     0.12     1
   687   107   SER       CB    C     63.87     0.12     1
   688   107   SER       N     N    113.42     0.12     1
   689   108   LEU       H     H      7.12     0.01     1
   690   108   LEU       HA    H      4.26     0.01     1
   691   108   LEU       HG    H      1.72     0.01     1
   692   108   LEU       HD1   H      0.76     0.01     1
   693   108   LEU       HD2   H      0.61     0.01     1
   694   108   LEU       C     C    177.55     0.12     1
   695   108   LEU       CA    C     54.35     0.12     1
   696   108   LEU       CG    C     26.21     0.12     1
   697   108   LEU       CD1   C     22.49     0.12     1
   698   108   LEU       CD2   C     27.00     0.12     1
   699   108   LEU       N     N    122.98     0.12     1
   700   109   SER       H     H      8.61     0.01     1
   701   109   SER       C     C    174.76     0.12     1
   702   109   SER       CA    C     57.11     0.12     1
   703   109   SER       N     N    119.46     0.12     1
   704   110   LEU       H     H      8.75     0.01     1
   705   110   LEU       HA    H      3.62     0.01     1
   706   110   LEU       HB2   H      1.44     0.01     2
   707   110   LEU       HG    H      1.38     0.01     1
   708   110   LEU       HD1   H      0.71     0.01     1
   709   110   LEU       HD2   H      0.63     0.01     1
   710   110   LEU       C     C    178.96     0.12     1
   711   110   LEU       CA    C     58.90     0.12     1
   712   110   LEU       CB    C     40.81     0.12     1
   713   110   LEU       CG    C     26.81     0.12     1
   714   110   LEU       CD1   C     24.05     0.12     1
   715   110   LEU       CD2   C     23.68     0.12     1
   716   110   LEU       N     N    122.73     0.12     1
   717   111   ALA       H     H      8.29     0.01     1
   718   111   ALA       HA    H      3.71     0.01     1
   719   111   ALA       HB    H      1.13     0.01     1
   720   111   ALA       C     C    180.88     0.12     1
   721   111   ALA       CA    C     55.20     0.12     1
   722   111   ALA       CB    C     18.02     0.12     1
   723   111   ALA       N     N    119.97     0.12     1
   724   112   GLN       H     H      7.58     0.01     1
   725   112   GLN       C     C    177.93     0.12     1
   726   112   GLN       CA    C     57.99     0.12     1
   727   112   GLN       N     N    118.83     0.12     1
   728   113   ARG       H     H      8.34     0.01     1
   729   113   ARG       C     C    179.47     0.12     1
   730   113   ARG       CA    C     60.73     0.12     1
   731   113   ARG       N     N    119.08     0.12     1
   732   114   ARG       H     H      8.30     0.01     1
   733   114   ARG       HA    H      3.74     0.01     1
   734   114   ARG       HB2   H      1.50     0.01     2
   735   114   ARG       HG2   H      1.49     0.01     2
   736   114   ARG       HG3   H      1.38     0.01     2
   737   114   ARG       HD2   H      2.86     0.01     9
   738   114   ARG       C     C    178.25     0.12     1
   739   114   ARG       CA    C     58.80     0.12     1
   740   114   ARG       CB    C     29.42     0.12     1
   741   114   ARG       CG    C     27.30     0.12     1
   742   114   ARG       CD    C     43.09     0.01     1
   743   114   ARG       N     N    120.21     0.12     1
   744   115   GLY       H     H      7.49     0.01     1
   745   115   GLY       C     C    175.83     0.12     1
   746   115   GLY       CA    C     44.74     0.12     1
   747   115   GLY       N     N    111.15     0.12     1
   748   116   PHE       H     H      7.71     0.01     1
   749   116   PHE       C     C    175.09     0.12     1
   750   116   PHE       CA    C     62.97     0.12     1
   751   116   PHE       N     N    119.58     0.12     1
   752   117   THR       H     H      7.56     0.01     1
   753   117   THR       HA    H      3.77     0.01     1
   754   117   THR       HB    H      4.04     0.01     1
   755   117   THR       HG2   H      1.17     0.01     1
   756   117   THR       C     C    175.22     0.12     1
   757   117   THR       CA    C     64.52     0.12     1
   758   117   THR       CB    C     69.29     0.12     1
   759   117   THR       CG2   C     21.77     0.12     1
   760   117   THR       N     N    106.62     0.12     1
   761   118   LYS       H     H      7.90     0.01     1
   762   118   LYS       HA    H      4.38     0.01     1
   763   118   LYS       HB2   H      1.62     0.01     2
   764   118   LYS       HB3   H      1.57     0.01     2
   765   118   LYS       HG2   H      1.16     0.01     2
   766   118   LYS       HG3   H      1.11     0.01     2
   767   118   LYS       HD2   H      1.45     0.01     2
   768   118   LYS       C     C    176.72     0.12     1
   769   118   LYS       CA    C     59.19     0.12     1
   770   118   LYS       N     N    119.71     0.12     1
   771   119   THR       H     H      8.09     0.01     1
   772   119   THR       HA    H      3.98     0.01     1
   773   119   THR       HG2   H      0.84     0.01     1
   774   119   THR       C     C    177.34     0.12     1
   775   119   THR       CA    C     65.22     0.12     1
   776   119   THR       N     N    110.90     0.12     1
   777   120   TYR       H     H      9.29     0.01     1
   778   120   TYR       C     C    178.43     0.12     1
   779   120   TYR       CA    C     56.72     0.12     1
   780   120   TYR       N     N    123.73     0.12     1
   781   121   THR       H     H      7.95     0.01     1
   782   121   THR       HA    H      3.97     0.01     1
   783   121   THR       HB    H      4.07     0.01     1
   784   121   THR       HG2   H      1.14     0.01     1
   785   121   THR       C     C    175.66     0.12     1
   786   121   THR       CA    C     65.02     0.12     1
   787   121   THR       CB    C     68.48     0.12     1
   788   121   THR       CG2   C     21.17     0.12     1
   789   121   THR       N     N    112.41     0.12     1
   790   122   VAL       H     H      7.01     0.01     1
   791   122   VAL       HA    H      3.92     0.01     1
   792   122   VAL       HB    H      2.04     0.01     1
   793   122   VAL       HG1   H      0.78     0.01     1
   794   122   VAL       C     C    177.15     0.12     1
   795   122   VAL       CA    C     63.59     0.12     1
   796   122   VAL       CB    C     31.25     0.12     1
   797   122   VAL       CG1   C     20.64     0.12     1
   798   122   VAL       N     N    117.82     0.12     1
   799   123   GLY       H     H      7.86     0.01     1
   800   123   GLY       HA2   H      3.61     0.01     2
   801   123   GLY       HA3   H      4.01     0.01     2
   802   123   GLY       C     C    174.74     0.01     1
   803   123   GLY       CA    C     45.39     0.12     1
   804   123   GLY       N     N    108.13     0.12     1
   805   124   CYS       H     H      7.74     0.01     1
   806   124   CYS       HA    H      4.64     0.01     1
   807   124   CYS       HB2   H      3.28     0.01     2
   808   124   CYS       HB3   H      2.82     0.01     2
   809   124   CYS       C     C    174.87     0.12     1
   810   124   CYS       CA    C     54.16     0.12     1
   811   124   CYS       CB    C     37.61     0.12     1
   812   124   CYS       N     N    117.57     0.12     1
   813   125   GLU       H     H      8.31     0.01     1
   814   125   GLU       HA    H      4.16     0.01     1
   815   125   GLU       HB2   H      1.79     0.01     2
   816   125   GLU       HB3   H      1.93     0.01     2
   817   125   GLU       HG2   H      2.13     0.01     2
   818   125   GLU       HG3   H      2.08     0.01     2
   819   125   GLU       C     C    175.32     0.12     1
   820   125   GLU       CA    C     56.80     0.12     1
   821   125   GLU       CB    C     29.92     0.12     1
   822   125   GLU       CG    C     35.75     0.12     1
   823   125   GLU       N     N    121.97     0.12     1
   824   126   GLU       H     H      7.94     0.01     1
   825   126   GLU       HA    H      3.95     0.01     1
   826   126   GLU       HB2   H      1.71     0.01     2
   827   126   GLU       HB3   H      1.85     0.01     2
   828   126   GLU       HG2   H      2.03     0.01     2
   829   126   GLU       CA    C     58.18     0.12     1
   830   126   GLU       CB    C     30.72     0.12     1
   831   126   GLU       CG    C     36.29     0.12     1
   832   126   GLU       N     N    127.00     0.12     1

   stop_

save_


#######################################
#  Cited references within the entry  #
#######################################

save_entry_reference_1
   _Saveframe_category     citation

   _PubMed_ID              .
   _Citation_title        
;
Global Orientation of Bound MMP-3 and N-TIMP-1 in Solution via Residual Dipolar 
Couplings
;
   _Citation_type          journal

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

       1   Arumugam    S.      .   . 
       2  "Van Doren"  Steven  R.  . 

   stop_

   _Journal_abbreviation   Biochemistry
   _Journal_volume         ?
   _Page_first             ?
   _Page_last              ?
   _Year                   ?

   loop_
      _Keyword

      "protein-protein interactions" 
      "docking"                      
      "residual dipolar couplings"   
      "NMR"                          

   stop_

save_

